The immunological profile of tumor-bearing animals determines the outcome of cancer immunotherapy

OncoImmunology

Volumn 2, Issue 6, 2013, Pages

  Quetglas, José I ^a   Stubbs, Sandra Hervas ^a   Smerdou, Cristian ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Alphavirus; Cancer immunotherapy; IL 12; IL 15R ; Liver secondary tumor

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RESISTANCE; CAUSE OF DEATH; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SEMLIKI FOREST ALPHAVIRUS; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR IMMUNITY; UPREGULATION;

EID: 84886945631     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.24499     Document Type: Article

References (9)

1. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
2. Mellman I, Coukos G, DranoffG. Cancer immunotherapy comes of age. Nature 2011; 480:480-9; PMID:22193102; http://dx.doi.org/10.1038/nature10673
3. Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH. Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 2007; 7:1705-21; PMID:17961093; http://dx.doi. org/10.1517/14712598.7.11.1705
4. Rodriguez-Madoz JR, Prieto J, Smerdou C. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas. Mol Ther 2005; 12:153-63; PMID:15963931; http://dx.doi.org/10.1016/j. ymthe.2005.02.011
5. Quetglas JI, Ruiz-Guillen M, Aranda A, Casales E, Bezunartea J, Smerdou C. Alphavirus vectors for cancer therapy. Virus Res 2010; 153:179-96; PMID:20692305; http://dx.doi.org/10.1016/j. virusres.2010.07.027
6. Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, et al. Cancer therapy using a selfreplicating RNA vaccine. Nat Med 1999; 5:823-7; PMID:10395329; http://dx.doi.org/10.1038/10548
7. Hidmark AS, Nordström EK, Dosenovic P, Forsell MN, Liljeström P, Karlsson Hedestam GB. Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling. J Virol 2006; 80:7100-10; PMID:16809315; http://dx.doi.org/10.1128/JVI.02579-05
8. Quetglas JI, Rodriguez-Madoz JR, Bezunartea J, Ruiz- Guillen M, Casales E, Medina-Echeverz J, et al. Eradication of liver-implanted tumors by semliki forest virus expressing IL-12 requires efficient long-term immune responses. J Immunol 2013; 190:2994-3004; PMID:23401594; http://dx.doi.org/10.4049/jimmunol. 1201791
9. Schluns KS, Lefrançois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3:269-79; PMID:12669018; http://dx.doi. org/10.1038/nri1052